Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Catheter Precision
Its shares trade under the ticker VTAK. It has been listed since 27 September 2018. In the fiscal year to 31 December 2025, it reported revenue of $819,000 and a net loss of $17.2m. At that date it held total assets of $15.9m and shareholders' equity of $7.1m.
Ra Medical Systems, Inc. engages in the design, development and commercialization of excimer lasers for the treatment of vascular immune-mediated inflammatory diseases. The company is headquartered in Fort Mill, South Carolina. The company went IPO on 2018-09-27. The firm is engaged in providing new solutions to the market to improve the treatment of cardiac arrhythmias. The firm is focused on developing technology for electrophysiology procedures by collaborating with physicians and advancing its products. The company is developing and delivering electrophysiology products to provide patients, hospitals, and physicians with technologies and solutions to improve the lives of patients with cardiac arrhythmias. Its products include Amigo, VIVO, and LockeT. Amigo is a remote catheter system, which uses an open architecture design, making it possible to use the system for additional catheter procedures. VIVO is a non-invasive three-dimensional (3D) imaging system that enables physicians to identify the origin of arrhythmias pre-procedure, streamlining workflow and reducing overall procedure time. LockeT is a suture retention device intended for wound healing.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Listed since
- 27 Sept 2018
- Employees
- 14
- Website
- ramed.com ↗
Leadership
Pay as last reported
- Mr. David JenkinsExecutive Chairman of the Board, Chief Executive Officer, Chief Commercial Officer, since 2023$300,000
- Mr. Philip AndersonChief Financial Officer, Secretary
- Mr. Andrew ArnoIndependent Director$15,000
- Mr. James CarusoIndependent Director$49,538
- Mr. Martin ColombattoIndependent Director$49,538
- Mr. Tony DacostaInvestor Relations, since 2023
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Ra Medical Systems develops innovative electrophysiology products like Amigo and VIVO for cardiac arrhythmias treatment.
- The company collaborates with physicians to advance electrophysiology technology and improve patient outcomes.
- Amigo, VIVO, and LockeT provide advanced solutions for cardiac arrhythmia procedures in the Health Care sector.
Weaknesses
- Ra Medical Systems has only 14 employees, which may limit operational capacity and scalability.
- The company's IPO in 2018 may indicate limited financial resources for expansion.
- Ra Medical Systems operates from Fort Mill, South Carolina, a location with limited industry presence.
Opportunities
- The growing demand for electrophysiology solutions in the Health Care sector presents expansion opportunities.
- Ra Medical Systems can leverage its product portfolio to enter new markets like Europe and Asia.
- Collaborations with hospitals and physicians can drive further adoption of Amigo and VIVO systems.
Threats
- Ra Medical Systems faces competition from established medical device companies in the Health Care sector.
- Regulatory changes in the Health Care industry could impact product approvals and market access.
- The small employee count of 14 may hinder the company's ability to respond to market challenges.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.